Alnylam Pharma(MX:ALNY)
MX$2,950.00+40.00 (+1.37%)
MX:ALNY
Alnylam Pharma earnings date
MX$2,950.00
At close:+40.00 (+1.37%)
Alnylam Pharma (ALNY) Q1 2024 Earnings Report
0 Followers
MX:ALNY Q1 2024 EPS Results
- Actual EPS
- -MXN 9.65
- Consensus EPS
- -MXN 20.71
- Beat/Miss
- Beat by +MXN 11.06
- One Year Ago EPS
- -MXN 25.98
MX:ALNY Q1 2024 Revenue Results
- Actual Revenue
- MXN 9.17B
- Expected Revenue
- MXN 7.94B
- Beat/Miss
- Beat by +MXN 1.23B
- YoY Revenue Growth
- +54.82%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 05/02/2024
- Time
- Before Open
- Conference Call
- Thursday, May 2, 2024
MX:ALNY Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q1 2024 Earnings Call Audio
MX:ALNY Q1 2024 Earnings Call
0:00 / 0:00
Q1 2024 Earnings Slide Deck
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ALNY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 31.94- | 15.22 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 30.80291.71 | 34.14 | 754.35% (+257.57) | |
| Jul 30, 2026 | 2026 (Q2) | 30.2522.45 | -9.46 | 337.25% (+31.92) | |
| Apr 30, 2026 | 2026 (Q1) | 16.1828.02 | -8.16 | 443.18% (+36.19) | |
| Feb 12, 2026 | 2025 (Q4) | 21.3415.22 | -12.06 | 226.15% (+27.28) | |
| Oct 30, 2025 | 2025 (Q3) | 10.4134.14 | -16.14 | 311.49% (+50.29) | |
| Jul 31, 2025 | 2025 (Q2) | -10.09-9.46 | -2.41 | -292.31% (-7.05) | |
| May 01, 2025 | 2025 (Q1) | -16.52-8.16 | -9.65 | 15.38% (+1.48) | |
| Feb 13, 2025 | 2024 (Q4) | -10.99-12.06 | -20.41 | 40.91% (+8.35) | |
| Oct 31, 2024 | 2024 (Q3) | -17.02-16.14 | 21.34 | -175.65% (-37.48) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


